Rationale: Serratia marcescens (S. marcescens) is an opportunistic pathogen of the Enterobacteriaceae family. Although S. marcescens is known to cause sepsis, meningitis, endocarditis, urinary system and ocular infections, skin infections are sporadic. Squamous cell carcinoma (SCC) is the most aggressive skin cancer type that is often located in the head and neck region, and rarely in the scalp tissue.
Introduction
Approximately 75% of all skin cancers have been observed to affect the head and neck region mostly, and rarely the scalp. [1, 2] Skin cancers can be broadly categorized into 2 groups: melanoma and nonmelanoma (NMSCs). Worldwide, nearly 40% of all cancers are NMSCs. NMSCs consists of 95% of all skin cancers. [3] Squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) are the 2 subgroups of NMSCs. Though SSC is the most aggressive type of skin cancer, it hardly ever occurs in the scalp. Moreover, intracranial invasion of SCC is extremely rare. [4] [5] [6] Serratia (S) marcescens is a gram-negative, motile, facultative anaerobic bacillus from Enterobacteriaceae family. It may cause nosocomial infections, and rarely be the reason of cutaneous infections in immunosuppressed patients. [7] Some biotypes of S. marcescens produce a red pigment called prodigiosin. Both pigmented and nonpigmented biotypes may constitute pathogeny for humans. In recent years, there have been published reports suggesting that pigmented strains of S. marcescens may be used in the cancer treatment. Successful results were obtained after it was tested in the treatment of acute lymphoblastic leukemia and SCC. [8, 9] Since nonpigmented biotypes cause more serious and difficultto-treat infections due to the cytotoxin production and antibiotic resistance, identification must be performed. [10] Many reports have been published in literature on this microorganism which is especially observed in immunosuppressed patients and may cause nosocomial infections. However, there are not any reports up to this date suggesting it causes cutaneous infections by colonization on the SCC tissue. The purpose of this report is to emphasize the unusual location of skin cancer (SCC), and the co-occurrence of nonpigmented S. marcescens.
Case presentation
An 89-year old male patient applied to our clinic with fatigue and lack of appetite complaints. He had no history of cancer in the family and his past but had a 30 pack/y smoking history. He was under follow-up for the previously diagnosed hypertension and atherosclerosis. During the physical examination painful, bleeding, heterogeneous, ulcerated tumor in the frontal region of the scalp, which has irregular borders and an exophytic growth pattern was seen. The growth of the tumor was gradual over the last 3 years. However, in the last 6 months, it grew rapidly. The destruction of the frontal bone made the pulsating brain tissue visible ( Figs. 1 and 2 ). The patient did not have hepatosplenomegaly or palpable lymph nodes. There were not any neurologic deficits, and all the other system examinations were normal. The patient was diagnosed with SCC 3 years ago but refused the surgical treatment. However, the option of surgery was not considered in this time because of the high risk caused by the tumoral invasion of the calvarium. The lower part of the tumor, that has grown rapidly in the last 6 months, had hemopurulent discharge (Fig. 3) . The laboratory findings were as follows; hemoglobin:12 g/dL (14-18), leukocyte:14,700/mm 3 (4000-10,000), C-reactive protein: 9. (Fig. 4) . BD Phoenix automated microbiology system (Becton Dickinson Diagnostic Systems, Sparks, MD) was used for the 
Discussion
SCC is the most aggressive type of skin cancer, which is generally located on the head and neck region, and it is rarely located on the scalp unlike we observed in our case. Nevertheless, calvarium invasion is also rare. [4] [5] [6] Malignant tumors of the scalp grow and spread progressively, and they even may reach calvarium. High rates of cure may be provided in localized SCC. While SCC with calvarium metastasis was considered inoperable and incurable in the past, it is possible to obtain successful results in recent years with the advanced novel surgical methods. [11] However, the fact that our case was 89-years old and evaluated in the high-risk group, surgical treatment was not possible.
S marcescens is the most commonly isolated Serratia species that affect the human race. Being the cause of cutaneous infections is rare for this bacteria since it generally causes nosocomial infections, and the first reports of cutaneous infections caused by S marcescens were published in 1973. [12] The most frequent skin infections caused by S marcescens are necrotizing fasciitis and cellulitis. The limited number of case reports have indicated S marcescens as the cause of skin infections, and these situations may occur by forming superinfection with other microorganisms. These are severe infections with a fatal course that are mostly observed in immunosuppressed patients. [13] [14] [15] [16] We also observed S marcescens proliferate in the culture originating from the hemopurulent exudate sample that was taken from the SCC lesion.
In recent years, some studies have been conducted to investigate the effect of S marcescens on cancer treatment. Cheng et al [9] tested a naturally red pigment named prodigiosin which is present in human oral squamous carcinoma cells as a secondary metabolite of this bacteria. Prodigiosin was shown to stimulate apoptosis and cause the cell cycle to stop in cancer cells in various concentrations and time periods. [9] Mostly, Serratia isolates are resistant to ampicillin and firstgeneration cephalosporins. However, many isolates of S marcescens are resistant to other cephalosporins, aminoglycosides, and even carbapenems. Hence, the treatment of infections caused by S marcescens is complex. [17] According to the wound culture results of our patient, it was determined to be susceptible to amikacin, gentamycin, piperacillin/tazobactam, cefepime, ceftriaxone, ciprofloxacin, imipenem, meropenem, ertapenem, and trimethoprim-sulfamethoxazole and resistant to ampicillin, amoxicillin-clavulanate, colistin, and cefuroxime. We initiated ciprofloxacin treatment.
Nonpigmented S marcescens biotypes are more fatal due to the cytotoxin production and antibiotic resistance. [10] Identification must be correct since nonpigmented biotypes as we observed in our case cause severe and complicated infections. Thus, the treatment is more difficult and challenging, and the mortality and morbidity rates of immunosuppressant patients are already high. We consider that the colonization of bacteria on the cancerous skin tissue facilitated both the spread of carcinoma tissue and bone invasion. However, it is not possible to make this conclusion depending on only 1 case; it may just be a cooccurrence.
The patient was lost during the follow-up after the initiation of the antibiotic treatment. Therefore we were unable to assess his response to treatment and to prove our estimation that nonpigmented S marcescens facilitated the expansion of SCC and its spread to calvarium.
Conclusion
Purulent exudate in skin cancers may be due to the nature of carcinoma tissue and the colonization of opportunistic pathogen microorganisms as it was in our case. Wound cultures and elimination of infectious agents are important in these cases. Otherwise, the success of treatment on the primary tumor may be affected in elder, immunosuppressed patients with comorbidities as in our case, and it may cause increased mortality and morbidity. 
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